Interest in lysosomal storage diseases (LSDs) has increased significantly, because several new therapeutics received FDA approval in 2003. Though long overlooked by most major pharmaceutical ...

The Philippine Health Insurance Corporation (PhilHealth) on Tuesday announced that it will soon expand its coverage to rare ...

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have recently developed a ...

Researchers from the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences have recently developed a neotype lysosomal trap for clearing viruses and variants. This lysosomal ...

Researchers have identified a potential treatment for Sandhoff and Tay-Sachs diseases -- two rare, often fatal lysosomal storage disorders that cause progressive damage to nerve cells in the brain ...

The Philippine Health Insurance Corporation (PhilHealth) said on Tuesday that it will expand its healthcare packages soon to ...

The Lysosomal Storage Disorders Support Society of India (LSDSS), a support group advocating for rare-disease patients, has ...

The Lysosomal Metabolomics and pH Core’s overarching goal is to understand the mechanistic link between lysosomal activity and aging in Alzheimer’s Disease. To accomplish this, the core will support ...

Patients with rare genetic disorders at AIIMS face life-threatening situations as government's funding runs dry. Despite court directives, funds remain unreleased. Families highlight urgent need for ...

Denali Therapeutics' innovative approach to neurological disorders and strong financial strategy position it as a leader in ...